Skip to content
10-Q

Quarterly Report

Adaptive Biotechnologies Corp ADPT

0001193125-25-267061

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 152.67M sh
Shares Diluted Q3 2025 · Sep 30, 2025 163.16M sh
Shares Diluted Q3 2025 · Sep 30, 2025 151.25M sh
Shares Diluted Q3 2025 · Sep 30, 2024 147.52M sh
Shares Diluted Q3 2025 · Sep 30, 2024 146.91M sh
Capex Q3 2025 · Sep 30, 2025 $2.32M
Capex Q3 2025 · Sep 30, 2024 $3.58M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$48.04M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$82.72M
Long Term Debt Q3 2025 · Sep 30, 2025 $129.41M
Long Term Debt Q3 2025 · Dec 31, 2024 $132.41M
Short Term Debt Q3 2025 · Sep 30, 2025 $2.43M
Short Term Debt Q3 2025 · Dec 31, 2024 $865K
Cash And Equivalents Q3 2025 · Sep 30, 2025 $55.03M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $47.92M
Stockholders Equity Q3 2025 · Sep 30, 2025 $204.44M
Stockholders Equity Q3 2025 · Dec 31, 2024 $202.71M
Current Liabilities Q3 2025 · Sep 30, 2025 $83.36M
Current Liabilities Q3 2025 · Dec 31, 2024 $98.05M
Total Liabilities Q3 2025 · Sep 30, 2025 $286.36M
Total Liabilities Q3 2025 · Dec 31, 2024 $336.89M
Current Assets Q3 2025 · Sep 30, 2025 $281.44M
Current Assets Q3 2025 · Dec 31, 2024 $283.75M
Total Assets Q3 2025 · Sep 30, 2025 $490.61M
Total Assets Q3 2025 · Dec 31, 2024 $539.38M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.06
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.30
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.22
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.86
Eps Basic Q3 2025 · Sep 30, 2025 $0.06
Eps Basic Q3 2025 · Sep 30, 2025 −$0.30
Eps Basic Q3 2025 · Sep 30, 2024 −$0.22
Eps Basic Q3 2025 · Sep 30, 2024 −$0.86
Sga Expense Q3 2025 · Sep 30, 2025 $17.96M
Sga Expense Q3 2025 · Sep 30, 2025 $53.14M
Sga Expense Q3 2025 · Sep 30, 2024 $17.26M
Sga Expense Q3 2025 · Sep 30, 2024 $54.75M
Rd Expense Q3 2025 · Sep 30, 2025 $23.67M
Rd Expense Q3 2025 · Sep 30, 2025 $72.01M
Rd Expense Q3 2025 · Sep 30, 2024 $24.16M
Rd Expense Q3 2025 · Sep 30, 2024 $79.76M
Net Income Q3 2025 · Sep 30, 2025 $9.55M
Net Income Q3 2025 · Sep 30, 2025 −$45.92M
Net Income Q3 2025 · Sep 30, 2024 −$32.07M
Net Income Q3 2025 · Sep 30, 2024 −$125.8M
Operating Income Q3 2025 · Sep 30, 2025 $10.29M
Operating Income Q3 2025 · Sep 30, 2025 −$44.35M
Operating Income Q3 2025 · Sep 30, 2024 −$32.63M
Operating Income Q3 2025 · Sep 30, 2024 −$128.71M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $18.16M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $53.14M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $16.67M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $54.04M
Revenue Q3 2025 · Sep 30, 2025 $93.97M
Revenue Q3 2025 · Sep 30, 2025 $205.3M
Revenue Q3 2025 · Sep 30, 2024 $46.44M
Revenue Q3 2025 · Sep 30, 2024 $131.5M